ScholarIQanswers from OpenAlex & ORCID
Robert Pordy
ResearcherPublications, citations & collaboration network
Robert Pordy is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Robert Pordy have?
ScholarIQindexed works
Robert Pordy has 192 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Robert Pordy have?
ScholarIQcitation count
Robert Pordy has 17,345 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Robert Pordy?
ScholarIQh-index
Robert Pordy has an h-index of 48 in OpenAlex.
What is the i10-index of Robert Pordy?
ScholarIQi10-index
Robert Pordy has an i10-index of 82 in OpenAlex.
What is the ORCID of Robert Pordy?
ScholarIQorcid
The ORCID for Robert Pordy is on the source record.
What is the OpenAlex record for Robert Pordy?
ScholarIQopenalex
The OpenAlex for Robert Pordy is on the source record.
What are the most-cited papers on Robert Pordy?
ScholarIQmost cited works
Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
Gregory G. Schwartz, Philippe Gabríel Steg, Michael Szarek, Deepak L. Bhatt, Vera Bittner, Rafael Díaz, Jay M. Edelberg, Shaun G. Goodman, Corinne Hanotin, Robert A. Harrington, J. Wouter Jukema, Guillaume Lecorps, Kenneth W. Mahaffey, Angèle Moryusef, Robert Pordy, Kirby Quintero, Matthew T. Roe, William J. Sasiela, Jean‐François Tamby, Pierluigi Tricoci, Harvey D. White, Andreas M. Zeiher
Effect of alirocumab, a monoclonal antibody to PCSK9, on long-term cardiovascular outcomes following acute coronary syndromes: Rationale and design of the ODYSSEY Outcomes trial
Gregory G. Schwartz, Laurence Bessac, Lisa G. Berdan, Deepak L. Bhatt, Vera Bittner, Rafael Díaz, Shaun G. Goodman, Corinne Hanotin, Robert A. Harrington, J. Wouter Jukema, Kenneth W. Mahaffey, Angèle Moryusef, Robert Pordy, Matthew T. Roe, Tyrus Rorick, William J. Sasiela, Cheerag Shirodaria, Michael Szarek, Jean‐François Tamby, Pierluigi Tricoci, Harvey D. White, Andreas M. Zeiher, Philippe Gabríel Steg
Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial
Kausik K Ray, Helen M Colhoun, Michael Szarek, Marie T. Baccara‐Dinet, Deepak L. Bhatt, Vera Bittner, Andrzej Budaj, Rafael Díaz, Shaun G Goodman, Corinne Hanotin, Robert A Harrington, J. Wouter Jukema, Virginie Loizeau, Renato D. Lópes, Angèle Moryusef, Jan Murin, Robert Pordy, Arsen Ristić, Matthew T. Roe, José Tuñón, Harvey D. White, Andreas M. Zeiher, Gregory G. Schwartz, Philippe Gabríel Steg, Gregory G. Schwartz, Philippe Gabríel Steg, Deepak L. Bhatt, Vera Bittner, Rafael Díaz, Shaun G. Goodman, Robert A. Harrington, J. Wouter Jukema, Michael Szarek, Harvey D. White, Andreas M. Zeiher, Pierluigi Tricoci, Matthew T. Roe, Kenneth W. Mahaffey, Jay M. Edelberg, Corinne Hanotin, Guillaume Lecorps, Angèle Moryusef, Robert Pordy, William J. Sasiela, Jean‐François Tamby, Philip E. Aylward, Heinz Drexel, Peter Sinnaeve, Mirza Dilić, Renato D. Lópes, Nina Gotcheva, Juan Carlos Prieto, Yong Huo, Patricio López‐Jaramillo, Ivan Pećin, Željko Reiner, Petr Ostadal, Margus Viigimaa, Markku S. Nieminen, Vakhtang Chumburidze, Nikolaus Marx, Nicolas Danchin, Evangelos Liberopoulos, Pablo Carlos Montenegro Valdovinos, Hung‐Fat Tse, Róbert Gábor Kiss, Denis Xavier, Doron Zahger, Marco Valgimigli, Takeshi Kimura, Hyo Soo Kim, Sang‐Hyun Kim, Andrejs Ērglis, Aleksandras Laucevičius, Saško Kedev, K. Yusoff, Gabriel Arturo Ramos López, Marco Alings, Sigrun Halvorsen, Roger M. Correa Flores, Andrzej Budaj, Joao Morais, Maria Dorobantu, Yuri Karpov, Arsen Ristić, Terrance Chua, Jan Murin, Zlatko Fras, Anthony J. Dalby, José Tuñón, H Asita de Silva, Emil Hagström, Ulf Landmesser, Chern‐En Chiang, Piyamitr Sritara, Sema Güneri, Alexander Parkhomenko, Kausik K. Ray, Patrick M. Moriarty, Robert A. Vogel